This page lists research consortia and projects related to STELLAR
REDDSTAR, Repair of Diabetic Damage by Stromal Cell Administration, is an EU funded project which will develop and test bone marrow derived stromal cell therapy to treat diabetes mellitus. The objective is to control blood glucose while also addressing a range of six diabetic complications.
EUROSTAM, A European wide strategy to enhance transplantation of highly sensitized patients on the basis of acceptable HLA mismatch, is an EU funded project which will investigate the feasibility and advantage to implement a Europe-wide acceptable mismatch program to facilitate transplantation of highly sensitized patients, who do not have a chance to be transplanted in their own population.
NEPHSTROM, is an EU financed consortium striving towards establishing the clinical safety and preliminary efficacy profile of Orbcel-M – a next generation, antibody-purified population of Mesenchymal Stromal Cells (MSCs) from human bone marrow – for the treatment of DKD in order to develop an entirely new treatment option for patients with this devastating disease.
RETHRIM, is an EU sponsored research consortium that has initiated the first multi-centre, double blind placebo controlled phase III clinical trial in Europe to investigate the usefulness of Mesenchymal Stromal Cells for the treatment of Graft-versus-Host-Disease.